课题基金 / 基金详情

Impact of hepatic perfusion on lobular and lobar distribution of test compound metabolism in rats

Impact of hepatic perfusion on lobular and lobar distribution of test compound metabolism in rats
肝灌注对大鼠试验化合物代谢的小叶和脑叶分布的影响
批准号:
447296368
负责人:
Professorin Dr. Uta Dahmen
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Units
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Professorin Dr. Uta Dahmen的其他基金

相似基金

相关文献

中文摘要
翻译
接受扩大肝切除术((e)PHx)的患者发生术后肝功能障碍甚至肝功能衰竭的风险很高,特别是在既存肝病的情况下。我们的研究小组LiPerF旨在使用系统医学方法,加强对手术后健康,脂肪变性和再生肝脏的肝脏灌注和功能之间的定量和空间关系的理解。本项目将重点评估灌注扰动和灌注损伤对肝功能丧失和恢复的影响。我们假设灌注的空间不均匀性与肝细胞的功能表现及其在再生过程中的增殖相匹配。我们的目的是通过a)在小叶和小叶尺度上对肝灌注和脂肪变性进行空间分辨定量,B)探索与肝细胞增殖相关的测试化合物代谢的能力和空间分布,评估肝灌注对正常、脂肪变性和再生肝中测试化合物代谢的影响。我们将在大鼠模型中使用三种不同的灌注扰动方法在多个尺度上研究肝灌注损伤:肝脂肪变性、门静脉结扎和肝切除。将使用侧流暗场成像和显示组织氧合的光学传感器对动物进行肝脏血流动力学和微循环的详细评估。探测多个肝叶将揭示肝脏灌注的异质性。测试化合物代谢用于肝功能的跨尺度评估。我们将在应用五种不同的测试化合物后进行药代动力学研究。我们将分析这些药物的代谢,通过测定相应的β-内酰胺酶活性、测量蛋白质和mRNA水平以及测定从不同肝叶获得的组织样本中的区域表达来解释异质性。术后即刻和术后第一周内,将通过肝/体重比、体积和功能恢复以及肝细胞增殖来评估肝再生,并将这些结果与详细的肝脏体积、灌注和功能MRI评估进行比较。我们的研究结果将补充调查的碳水化合物/脂质代谢和详细的基因表达分析。因此,一个全面的网络的代谢控制评估作为肝脏灌注的函数将被生成。所有的实验数据连同相应的临床数据将作为输入的集成计算模型所需的空间分辨预测再生和功能恢复的肝脏手术后的未来肝脏残余。因此,接受(e)PHX的患者的功能预测和风险分层将得到改善。
英文摘要
Patients subjected to extended liver resection ((e)PHx) have a high risk to experience postoperative liver dysfunction or even liver failure, especially in case of preexisting liver disease. Our research group QuaLiPerF aims to enhance the understanding of the quantitative and spatial relationship between hepatic perfusion and function in healthy, steatotic and regenerating livers after surgery using a systems medicine approach. This project will focus on assessing the impact of perfusion perturbation and perfusion impairment on loss and recovery of liver function. We hypothesize that spatial inhomogeneity of perfusion matches the functional performance of the hepatocytes and their proliferation during regeneration. It is our aim to assess the impact of hepatic perfusion on test compound metabolism in normal, steatotic and regenerating livers by a) spatially resolved quantification of hepatic perfusion and steatosis on the lobular and lobar scale,b) exploring the capacity and spatial distribution of test compound metabolism in relation to hepatocyte proliferation.To reach this goal, we are going to investigate liver perfusion impairments on multiple scales using three different approaches of perfusion perturbation in the rat model: hepatic steatosis, portal vein ligation, and liver resection. Animals will be subjected to detailed assessment of hepatic hemodynamics and microcirculation using side-stream dark field imaging and an optical sensor revealing the tissue oxygenation. Probing multiple liver lobes will reveal the heterogeneity of hepatic perfusion.Test compound metabolism is used for scale spanning assessment of hepatic function. We will perform pharmacokinetic studies after applying five different test compounds. We will analyze metabolism of these drugs by determination of the corresponding CYP enzyme activity, measurement of protein and mRNA levels and determination of zonal expression in tissue samples obtained from different liver lobes to account for heterogeneity. Liver regeneration will be assessed immediately after surgery and within the first postoperative week by addressing liver-to-body-weight ratios, volume and functional recovery as well as proliferation of hepatocytes.These results will be compared to detailed MRI assessment of liver volume, perfusion and function. Our results will be complementary to investigations of the carbohydrate/lipid metabolism and a detailed gene expression analysis. Thus, a comprehensive network of metabolic control assessment as a function of liver perfusion will be generated.All experimental data together with corresponding clinical data will serve as input for the integrated computational models needed for spatially resolved prediction of regeneration and functional recovery of the future liver remnant after liver surgery. As a result, prediction of function and risk stratification for patients undergoing (e)PHX will be improved.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modeling Pharmacokinetics in Steatotic Livers (SteaPKMod)
Modeling the pathogenesis of pericentral steatosisInfluence of oxygen on fat accumulation and production of reactive oxygen species
Central Microsurgical Unit
Risk and recovery of outflow obstrcution in living-related liver transplantation: The influence of liver perfusion on regeneration and outcome
国内基金
海外基金
蛋白磷酸酶1调节亚基3c(PPP1R3c)调控肝脏糖异生的作用及机制研究
  • 批准号:
    82370810
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陆洁莉
  • 依托单位:
以辣椒素受体为靶点抗肝纤维化作用的研究
  • 批准号:
    81071716
  • 项目类别:
    面上项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2010
  • 负责人:
    徐迅迪
  • 依托单位:
神经胶质成熟因子-β对肝星状细胞活化和肝纤维化的影响及其机制研究
  • 批准号:
    30800508
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    19.0万元
  • 批准年份:
    2008
  • 负责人:
    饶慧瑛
  • 依托单位:
骨髓间充质干细胞向肝脏星状细胞定向分化的构建及其在诱导同种异体胰岛细胞移植免疫耐受中的作用
  • 批准号:
    30872484
  • 项目类别:
    面上项目
  • 资助金额:
    32.0万元
  • 批准年份:
    2008
  • 负责人:
    尹震宇
  • 依托单位: